Reduction of Sweetened Beverages and Intrahepatic Fat
- Conditions
- ObesityMetabolic SyndromeDyslipidemia
- Interventions
- Other: artificially sweetened sodas
- Registration Number
- NCT01394380
- Lead Sponsor
- University of Lausanne
- Brief Summary
The study will enroll 68 overweight male and female subjects with a high (\> 2 3dl-can soda/day) consumption of sweetened beverage per day. After a run-in period of 4 weeks, subjects will be randomized to either a 12-week intervention arm in which sweetened beverages will be replaced by artificially sweetened, calorie-free beverages, or to a control arm. The following measurements will be performed at the end of the run-in period and at the end of the intervention period
* intrahepatic fat concentration
* visceral fat volume
* changes in day-long metabolic profile from baseline(plasma glucose, insulin, and triglyceride concentrations)
* changes in food intake and daily energy, carbohydrate and sugars intake from baseline
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 29
- gender male or female
- body mass index (BMI) > 27 kg/m2 consumption of > 2 3dl-can regular soda/day
- low to moderate physical activity (< 60 min walking/day; < 3 exercise session/week
- diabetes mellitus
- liver, kidney or heart disease
- any current drug treatment
- contra-indications to MR examination (pacemaker, foreign bodies,etc)
- pregnancy or planned pregnancy
- active weight gain or weight loss (weight change > 4 kg in the past 12 months)
- consumption of drugs or illicit substances
- consumption of more than 10g alcohol/day
- vegetarians or subjects on special diets
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description artificially sweetened beverages artificially sweetened sodas subjects will be required to consume only artificially-sweetened sodas, water, tea or coffee
- Primary Outcome Measures
Name Time Method changes in intrahepatic fat concentration at the end of run-in and after 12 weeks intervention/control intrahepatic fat content measured by 1H-MRS
- Secondary Outcome Measures
Name Time Method changes in food intake from baseline at the end of the run-in period and after 6, and 12 weeks of intervention/control Total energy intake, total carbohydrate intake, and total sugars intake will be evaluated by 3-day food record
changes in visceral fat volume at the end of run-in and after 12 weeks of intervention/control Visceral fat volume measured by MRI
changes in day-long metabolic profile at the end of run-in and after 12 weeks of intervention/control Plasma glucose, insulin, non-esterified fatty acids, and triglycerides will be measured at 2-hourly intervals between 7:00 am and 5:00 pm. Participants will be fed standardized meals and either sweetened or artificially-sweetened beverages according to randomization
Trial Locations
- Locations (1)
Clinical Research Center, CHUV
🇨ðŸ‡Lausanne, VD, Switzerland